Floatz logo

306 assets in B-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing B-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Humanized Cd19 Car-T Cells
B-Cell Non-Hodgkin Lymphoma
Zhejiang UniversityEarly P1C (39)
ic9-car19 t cells
B-Cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer CenterP1C (39)
imv101 treatment
B-Cell Non-Hodgkin Lymphoma
Suzhou Immunofoco Biotechnology Co., LtdEarly P1C (39)
Infusion Of Jy231
B-Cell Non-Hodgkin Lymphoma
Guangdong Second Provincial General HospitalEarly P1C (39)
jy231
B-Cell Non-Hodgkin Lymphoma
Affiliated Hospital of Guangdong Medical UniversityEarly P1C (39)
Keynatinib
B-Cell Non-Hodgkin Lymphoma
Medolution Ltd.P1C (39)
Kur-502
B-Cell Non-Hodgkin Lymphoma
Athenex, Inc.P1C (39)
Loxo-338
B-Cell Non-Hodgkin Lymphoma
Eli Lilly and CompanyP1C (39)
lp-168
B-Cell Non-Hodgkin Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P1C (39)
Lucar-E9D Or Lucar-E9K Cells Product
B-Cell Non-Hodgkin Lymphoma
Beijing GoBroad HospitalEarly P1C (39)
ly4152199 - iv
B-Cell Non-Hodgkin Lymphoma
Eli Lilly and CompanyP1C (39)
Metabolically Armed Cd19 Car-T Cells
B-Cell Non-Hodgkin Lymphoma
Zhejiang UniversityEarly P1C (39)
qn-019a
B-Cell Non-Hodgkin Lymphoma
Zhejiang UniversityP1C (39)
Retifanlimab
B-Cell Non-Hodgkin Lymphoma
University of Alabama at BirminghamP1C (39)
Rimiducid
B-Cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer CenterP1C (39)
Sirolimus
B-Cell Non-Hodgkin Lymphoma
Umoja BiopharmaP1C (39)
Tagraxofusp
B-Cell Non-Hodgkin Lymphoma
Therapeutic Advances in Childhood Leukemia ConsortiumP1C (39)
Triple-Targeted Car-T Therapy
B-Cell Non-Hodgkin Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdP1C (39)
Ub-Vv111
B-Cell Non-Hodgkin Lymphoma
Umoja BiopharmaP1C (39)
xs-04
B-Cell Non-Hodgkin Lymphoma
NovaOnco Therapeutics Co., Ltd.P1C (39)
rn1101
B-Cell Non-Hodgkin Lymphoma
YANRU WANGEarly P1C (38)
Anti-Cd19 Car Nk Cells
B-Cell Non-Hodgkin Lymphoma
Xuzhou Medical UniversityEarly P1C (36)
cta30x ucar-t
B-Cell Non-Hodgkin Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaEarly P1C (36)
Umbralisib
B-Cell Non-Hodgkin Lymphoma
Yazeed SawalhaP1C (34)
Anti-Cd19 Gene
B-Cell Non-Hodgkin Lymphoma
Anhui Provincial HospitalN/AD (30)
Brl-301
B-Cell Non-Hodgkin Lymphoma
Bioray LaboratoriesN/AD (30)
Jcxh-213,An Mrna-Lnp Based In Vivo Car Therapy
B-Cell Non-Hodgkin Lymphoma
Beijing GoBroad HospitalN/AD (30)
ms-553
B-Cell Non-Hodgkin Lymphoma
MingSight Pharmaceuticals, IncP1/2D (30)
Arv-393
B-Cell Non-Hodgkin Lymphoma
Arvinas Inc.P1NR ()
Atg-031
B-Cell Non-Hodgkin Lymphoma
Antengene Biologics LimitedP1NR ()
b019
B-Cell Non-Hodgkin Lymphoma
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.P1NR ()
CD19 CAR-DC
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1NR ()
Dose Expansion: The Maximum Tolerated Dose Of Car20.19.22 Cells
B-Cell Non-Hodgkin Lymphoma
Medical College of WisconsinP1NR ()
Fully Human Anti-Cd19/Cd22 Dual Target Chimeric Antigen Receptor Autologous T Cell
B-Cell Non-Hodgkin Lymphoma
Nanjing IASO Biotechnology Co., Ltd.P1/2NR ()
gb261
B-Cell Non-Hodgkin Lymphoma
Genor Biopharma Co., Ltd.P1/2NR ()
gi001
B-Cell Non-Hodgkin Lymphoma
Ruijin HospitalEarly P1NR ()
HP-002
B-Cell Non-Hodgkin Lymphoma
Shanghai Helioson Pharmaceutical Co., Ltd.P1/2NR ()
Jnj-88998377
B-Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1NR ()
Mivavotinib
B-Cell Non-Hodgkin Lymphoma
Calithera Biosciences, IncP2NR ()
Showing 251 to 300 of 306 assets
PreviousPage 6 of 7Next